Agilent Technologies

Enable Medicine Appoints Kamni Vijay as Chief Executive Officer

Retrieved on: 
Tuesday, February 13, 2024
Data Management, Biotechnology, Technology, Other Health, Health, General Health, Pharmaceutical, Research, Infectious Diseases, Artificial Intelligence, Science, Real-time, Doctor of Philosophy, Multimedia, AI, NIH, Dartmouth College, Growth, Bio-Rad Laboratories, Drug discovery, Entrepreneurship, BD (company), Polymerase chain reaction, COVID-19, UC, University of California, Davis, Molecular and Cellular Biology, Agilent Technologies, BIOS, Patient, Polymerase, PCR, Medicine, Pharmaceutical industry

Enable Medicine , a leader in AI for biological research and drug discovery, has announced the appointment of Kamni Vijay as Chief Executive Officer.

Key Points: 
  • Enable Medicine , a leader in AI for biological research and drug discovery, has announced the appointment of Kamni Vijay as Chief Executive Officer.
  • Mr. Bodapati remains Chairman of the Board and will transition to the role of Chief Strategy Officer.
  • “Kamni Vijay is highly respected in the life sciences and diagnostics industries,” said Elena Viboch, Partner at General Catalyst.
  • “Kamni brings to Enable extensive experience leading high-performing teams and is exactly the type of leader Enable needs as we advance into our next phase of growth,” said Sunil Bodapati, Chairman and Co-Founder, Enable Medicine.

Next-Generation Sequencing Emerging Clinical Applications and Global Markets, with Profiles of Leading Players Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies and BGI Genomics - ResearchAndMarkets.com

Retrieved on: 
Monday, February 12, 2024
Biotechnology, Genetics, Health, Agilent Technologies, BGI Group, Genetic disorder, Magnis, Illumina, Inc., DSM-IV codes, Genetic variation, Liquid biopsy, QIAGEN, Genomics, NGS, Marker beacon, Thermo Fisher Scientific, BGI, Fertilisation, Noninvasive prenatal testing, Genome, Informatics, CTC, Research, DNA, Medical device

The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The NGS platform enables companies to expand the menu of disorders/diseases over time after initial launch of a test.
  • The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents, and companies.
  • This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing.

In-Vitro Diagnostics Business Updates Service - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 8, 2024
Medical Devices, Health, Agilent Technologies, Cell biology, Prenatal development, Molecular diagnostics, Business, Pharmaceutical industry

Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023

Key Points: 
  • Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2022 and Fy 2023
    Figure: Agilent Sales, by Business (Agilent Crosslab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), Fy 2023 Quarterly Performance
    Figure: Agilent Fy 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia-Pacific, Europe) (%)
    Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2023 ($ Millions)
    Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), Fy 2022 and Fy 2023 ($ Millions)

Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products

Retrieved on: 
Thursday, February 8, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Media, Communications, ADCC, Tumor microenvironment, Agilent Technologies, CPE, RTCA, Drug discovery, Exhibition, Advantage Business Media, Conference, BioTek

Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.
  • These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development.
  • The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 – Screening Model was voted Best New Drug Discovery & Development Product of 2023.
  • The Drug Discovery & Development Webinar of the Year was co-produced between Agilent and Dr. Agapitos Patakas, Chief Scientific Officer, Antibody Analytics.

Agilent to Participate in TD Cowen Health Care Conference

Retrieved on: 
Wednesday, February 7, 2024
Technology, Research, Health Technology, Software, Biometrics, Hardware, Health, General Health, Science, EST, Agilent Technologies, Conference

Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST.

Key Points: 

Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST.

3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive growth -Technavio

Retrieved on: 
Monday, February 5, 2024
Advantage Business Media, ROW, Agilent Technologies, Laser, Materials science, 3D, Laboratory, Electromagnetic radiation, Ametek, Professional corporation, Aerospace, Hitachi, Danaher Corporation, White, CCU, Microscope

They are used in Materials Science for high-resolution imaging of materials' surface structures and properties.

Key Points: 
  • They are used in Materials Science for high-resolution imaging of materials' surface structures and properties.
  • In Atomic, Molecular, and Optical Physics, they enable precise visualization and analysis of atomic and molecular structures.
  • Moreover, 3D Optical Microscopes play a significant role in 3D Scanning and Image Segmentation for creating detailed 3D models and analyzing complex images.
  • What are the key data covered in this 3D Optical Microscope Market report?

Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology

Retrieved on: 
Tuesday, January 30, 2024
Oncology, Health, Technology, Health Technology, Software, Biotechnology, Partnership, Agilent Technologies, HER2, Conditional sentence, Breast, Therapy, Biomarker, Patient, IVD, Cancer, CDX, Translational medicine

Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio.
  • Developed for use with targeted therapeutics, companion diagnostics are used to evaluate expression of biomarkers and identify patients that are likely to benefit from treatment with the targeted therapeutic products.
  • The agreement between Agilent and Incyte allows the companies to collaborate on CDx development programs.
  • Paul Beresford, vice president and general manager of Agilent’s Companion Diagnostics Division, discussed the significance of the partnership: “Leveraging the power of companion diagnostics, we are strategically transforming the treatment paradigm for a broad spectrum of cancers.

Two-photon Laser Scanning Confocal Microscope Market to Record USD 282.95 Million Growth between 2023 to 2028, Market Share, Trends, Drivers, and Opportunity Assessment - Technavio

Retrieved on: 
Tuesday, January 30, 2024
Medication, PB, Research, ROW, Carl Zeiss AG, Danaher Corporation, Thermo Fisher Scientific, Pharmacy, Cancer, Growth, Signal-to-noise ratio, Bruker, Laser, FLIM, Acquisition, USD, Agilent Technologies, DSM-IV codes, Data analysis, PerkinElmer, Microscope

NEW YORK, Jan. 29, 2024 /PRNewswire/ -- The two-photon laser scanning confocal microscope market is estimated to grow by USD 282.95 million from 2023 to 2028 at a CAGR of 5.59% according to Technavio.

Key Points: 
  • NEW YORK, Jan. 29, 2024 /PRNewswire/ -- The two-photon laser scanning confocal microscope market is estimated to grow by USD 282.95 million from 2023 to 2028 at a CAGR of 5.59% according to Technavio.
  • Increasing life science research focusing on disease diagnosis has heightened the need for confocal microscopes.
  • These instruments are crucial for imaging live specimens in studies, aiding in the development of new diagnostic tools for conditions like cancer and neurological disorders.
  • The global scanning electron microscope (SEMs) market size is estimated to grow by USD 997.21 million at a CAGR of 8.01% between 2022 and 2027.

Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27

Retrieved on: 
Thursday, January 25, 2024
Software, Networks, Internet, Data Management, Technology, Apps, Applications, Mobile, Wireless, Security, PST, Agilent Technologies

Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27.
  • In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST.
  • To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations website.
  • A recording of the call will also be available on the website for 90 days.

Avantor® Recognizes Supplier Award Winners at 2024 Americas Sales Conference

Retrieved on: 
Friday, January 19, 2024
Agilent Technologies, Avantor, Science, AVTR, Oxford Nanopore Technologies, Conference, Marketing, Fine chemical

Supplier recognition is a key highlight of the conference, and the Avantor Supplier Awards recognizes excellence across a range of categories and product segments.

Key Points: 
  • Supplier recognition is a key highlight of the conference, and the Avantor Supplier Awards recognizes excellence across a range of categories and product segments.
  • The 2024 Supplier of the Year award is nominated by the Avantor sales organization, honoring the supplier's outstanding product, field support and marketing programs.
  • "Avantor's Americas Sales Conference is an opportunity to recognize the contributions and achievements of our suppliers and deepen collaboration with our sales organization.
  • Congratulations to all of our award winners," said Jim Bramwell, Executive Vice President, Sales and Customer Excellence at Avantor.